# FDA Inspection 1155017 - James G. Waxmonsky, MD - October 19, 2021

Source: https://www.keypedia.com/records/fda_inspections/james-g-waxmonsky-md/422b46b4-e92a-45e4-a11f-64176deea55d
Source feed: FDA_Inspections

> FDA Inspection 1155017 for James G. Waxmonsky, MD on October 19, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1155017
- Company Name: James G. Waxmonsky, MD
- Inspection Date: 2021-10-19
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/james-g-waxmonsky-md/dbbb70c1-d919-49dc-a021-f100cc9845e8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c